Fishers, IN, United States of America

Serge Louis Boulet

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 7.4

ph-index = 1


Company Filing History:


Years Active: 2008-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Of course! Here is an article about inventor Serge Louis Boulet:

Title: Inventor Profile: Serge Louis Boulet

Introduction:

Serge Louis Boulet is a prolific inventor based in Fishers, IN (US) who has made significant contributions to the field of cancer treatment through his innovative patented compounds. With 11 patents to his name, Boulet's work has garnered attention in the pharmaceutical industry for its potential impact on cancer therapy.

Latest Patents:

Among his latest patents are "KRas G12C inhibitors" and "7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors". These compounds offer promising avenues for the treatment of cancer, particularly in targeting mutations in key cancer-related genes.

Career Highlights:

Serge Louis Boulet is currently employed at Eli Lilly and Company, a renowned pharmaceutical corporation. His association with this esteemed company underscores his expertise and dedication to advancing cancer research and drug development.

Collaborations:

Notable collaborators of Serge Louis Boulet include Renato Alejandro Bauer and Timothy Paul Burkholder. Together, they form a dynamic team at Eli Lilly and Company, working towards innovative solutions in oncology and beyond.

Conclusion:

In conclusion, Serge Louis Boulet's commitment to innovation in cancer treatment is evident through his numerous patents and collaborations in the pharmaceutical industry. His cutting-edge research continues to pave the way for advancements in cancer therapy, offering hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…